Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna-Lena Hard

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinics in Perinatology|May 31, 2013
The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatmentLois E Smith, Anna-Lena Hard, Ann Hellström
Pediatric Research|August 22, 2003
Growth in very preterm children: a longitudinal studyAimon Niklasson, Eva Engstrom, Anna-Lena Hard, et al.
Current Pharmaceutical Design|October 4, 2017
IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical DevelopmentAnn Hellstrom, David Ley, Boubou Hallberg, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinics in Perinatology|May 31, 2013
The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatmentLois E Smith, Anna-Lena Hard, Ann Hellström
Pediatric Research|August 22, 2003
Growth in very preterm children: a longitudinal studyAimon Niklasson, Eva Engstrom, Anna-Lena Hard, et al.
Current Pharmaceutical Design|October 4, 2017
IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical DevelopmentAnn Hellstrom, David Ley, Boubou Hallberg, et al.
Pageof 1